Abstract
Breast cancer is the main cause of female malignancy worldwide. Effective early detection by imaging studies remains critical to decrease mortality rates, particularly in women at high risk for developing breast cancer. Breast Magnetic Resonance Imaging (MRI) is a common diagnostic tool in the management of breast diseases, especially for high-risk women. However, during this examination, both normal and abnormal breast tissues enhance after contrast material administration. Specifically, the normal breast tissue enhancement is known as background parenchymal enhancement: it may represent breast activity and depends on several factors, varying in degree and distribution in different patients as well as in the same patient over time. While a light degree of normal breast tissue enhancement generally causes no interpretative difficulties, a higher degree may cause difficulty to detect and classify breast lesions at Magnetic Resonance Imaging even for experienced radiologists. In this work, we intend to investigate the exploitation of some statistical measurements to automatically characterize the enhancement trend of the whole breast area in both normal and abnormal tissues independently from the presence of a background parenchy...Continue Reading
References
Dec 2, 1999·Radiology·U FischerE Grabbe
Apr 27, 2002·European Radiology·F BaumE Grabbe
Dec 8, 2009·Magnetic Resonance Imaging Clinics of North America·Elizabeth A Morris
Nov 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adriana J RijnsburgerJan G M Klijn
Dec 24, 2010·AJR. American Journal of Roentgenology·Niamh M HamblyElizabeth A Morris
Feb 18, 2011·European Radiology·Sanaz A JansenGillian M Newstead
Apr 16, 2011·Radiology·Valencia KingElizabeth A Morris
Mar 28, 2012·AJR. American Journal of Roentgenology·Wendy B DeMartiniConstance D Lehman
Oct 30, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M C Pike, C L Pearce
Jan 17, 2014·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Catherine S GiessRobyn L Birdwell
Apr 2, 2014·Breast Cancer Research and Treatment·D Gareth EvansStephen W Duffy
Apr 12, 2014·Magnetic Resonance Imaging·Marco MoschettaGiuseppe Angelelli
Jun 3, 2014·BMC Cancer·Hongmin CaiLi Li
Aug 17, 2014·Magnetic Resonance Imaging·Marco MoschettaGiuseppe Angelelli
Jun 29, 2015·Magnetic Resonance Imaging·Michele TelegrafoMarco Moschetta
Sep 19, 2015·Radiology·Cristina Gallego-Ortiz, Anne L Martel
Nov 26, 2015·Magnetic Resonance Imaging·Michele TelegrafoMarco Moschetta
Nov 26, 2015·PloS One·Jeff WangHiroki Shirato
Mar 14, 2016·Diagnostic and Interventional Imaging·M TelegrafoM Moschetta
Apr 25, 2016·Clinical Breast Cancer·Marco MoschettaGiuseppe Angelelli
May 20, 2017·Scientific Reports·Shandong WuDavid Gur
Aug 16, 2017·BioMed Research International·Yasuo AmanoMayumi Tani
Nov 21, 2017·NPJ Breast Cancer·Vishwa S Parekh, Michael A Jacobs
Citations
Apr 30, 2020·Technology in Cancer Research & Treatment·Dong-Man YeTao Yu
Dec 19, 2019·Journal of Nanobiotechnology·Yanlong JiaRenhua Wu
Jul 22, 2020·Physical and Engineering Sciences in Medicine·Gökçen ÇetinelSevda Gül
May 27, 2020·Scientific Reports·Shuang ZhaoJianqun Yu
Aug 23, 2020·Cancers·Alfonso FaustoMaria Antonietta Mazzei
Jun 27, 2019·Journal of Clinical Medicine·Annarita FanizziDaniele La Forgia
Sep 23, 2020·Diagnostics·Daniele La ForgiaAlfredo Zito
Feb 24, 2021·Technology in Cancer Research & Treatment·Tommaso PerrettaOreste Claudio Buonomo
Mar 30, 2021·Frontiers in Oncology·Raffaella MassafraVito Lorusso
May 1, 2021·Diagnostics·Raffaella MassafraDaniele La Forgia
May 1, 2021·Journal of Personalized Medicine·Daniele La ForgiaAnnarita Fanizzi
Jun 3, 2021·International Journal of Environmental Research and Public Health·Giulia BicchieraiJacopo Nori
Jun 3, 2021·Cancers·Maria Colomba ComesRaffaella Massafra
Aug 8, 2021·Diagnostics·Ioana Boca BeneSorin Marian Dudea
Jan 9, 2019··Anna Maria Lucia LanzollaAttilio Di Nisio